Long-term benefits of single-dose psilocybin in depressed patients with cancer.
Agrawal M, Roddy K, Jenkins B, Leeks C, Emanuel E
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (5)
- Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model 2026-12-01 · Expand citations
- Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis 2026-11-01 · Expand citations
- Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review 2026-09-10 · Expand citations
- Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy 2026-06-05 · Expand citations
- Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations